“…Over the last couple of years, we have seen the Journal publish highly impactful papers on a wealth of issues, including meta-analyses on the link between proton-pump inhibitors and hypomagnesemia [1], on the impact of overhydrated status and low lean tissue in end-stage renal disease (ESRD) patients [2], on uric acid lowering therapy and chronic kidney disease progression [3] and a systemic review and meta-analysis further confirming cinacalcet's lack of impact on survival in (ESRD) patients [4]. Single-center studies published in the Journal have explored the impact of AKI in donors on renal graft survival subsequent to renal transplantation [5], the risk of AKI after transcatheter aortic valve placement [6] and quality of life, as well as the correlation of personality profiles and coping styles with clinical outcomes in ESRD patients on maintenance hemodialysis [7]. Additional publications in the Journal have also explored the frequency and clinical characteristics of invasive fungal infections in renal transplant recipients [8], the value of combination biomarkers in predicting renal impairment after a cardiovascular bypass procedure [9], the clinical characteristics of sepsis-induced AKI from China [10], post-partum renal injury from India [11] outcomes and characteristics of AKI in hospitalized patients from sub-Saharan Africa.…”